ASAbdoulaye Sawadogo

Abdoulaye Sawadogo

*This is an algorithmically generated author record based on publicly available information.

Abdoulaye Sawadogo has a total of 84 co-authors. Here are the top co-authors by number of shared publications:

  • Ismaël Diallo

    Infectious Diseases and Tropical Medicine Department Yalgado Ouédraogo Teaching Hospital Burkina Faso

    3 shared publications
  • Appolinaire Kima

    National Program for the Control of Neglected Tropical Diseases (PNLMTN) Ministry of Health Burkina Faso

    2 shared publications
  • Armel Poda

    2 shared publications
  • Boukary Ouédraogo

    Department of Health Information Systems Ministry of Health Burkina Faso

    2 shared publications
  • Gafourou Arsène Ouédraogo

    University Hospital Yalgado Ouedraogo: Centre Hospitalier Universitaire Yalgado Ouedraogo

    2 shared publications
  • Jacques Zoungrana

    Infectious Diseases and Tropical Medecine Department, Teaching Hospital Sourô Sanou Bobo Dioulasso, University Nazi Boni Burkina Faso

    2 shared publications

Latest Publications

  • Open Access

    Knowledge, attitudes, and practices of Tougan population towards dengue in Burkina Faso in 2024

    by Ter Tiero E. Dah, Abdoul S. Moné, Désiré L. Dahourou, Kadari Cissé, Hamidou Savadogo, Nongognan I. Lengane, Zanga D. Ouattara, Abdoulaye Sawadogo, Linda A. Koubi, Isidore T. Traore, et al.

    Background: Recent dengue outbreaks in Burkina Faso have caused substantial morbidity and mortality among semi-urban and urban populations. Aim: To assess the knowledge, attitudes, and practices (KAP) among the population of Tougan, a semi-urban city, towards dengue. Setting: Between April 2024 and July 2024, a cross-sectional study was performed among residents and internally displaced populations (IDPs) in Tougan. Methods: Participants aged 18 years and older, recruited through an adapted three-stage random sampling were eligible. Sociodemographic data as well as information on knowledge, attitudes, and practices (KAP) were collected using a questionnaire. Factors associated with good knowledge of dengue (i.e. knowledge score ≥ 11) were identified using logistic regression models. Results: A total of 419 participants, including 130 (31.1%) IDPs, were enrolled in the study. The majority were male (53.9%), with a mean age of 38.5 years (standard deviation [s.d.] 12.9). The mean scores of KAP regarding dengue were 10.1 (s.d. 1.2), 13.5 (s.d. 1.9), and 9.4 (s.d. 2.2), respectively. Internally displaced populations had significantly lower levels of knowledge of dengue (adjusted odds ratio [aOR]: 0.49, 95% confidence interval [CI]: 0.29–0.81, p = 0.006) compared to residents. Moreover, participants with stagnant water at their home (aOR: 3.03, 95% CI: 1.84–4.96, p < 0.001) and those with good practices towards dengue (aOR: 3.39, 95% CI: 1.37–8.38, p = 0.008) had better knowledge. Conclusion: Context-specific prevention messages on dengue and targeted interventions should be developed for IDPs and residents from semi-urban areas in Burkina Faso. Contribution: This study provides findings to enhance dengue awareness among vulnerable populations and preparedness for future epidemics.

  • Impact of mass drug administration of ivermectin and albendazole on transmission of Wuchereria bancrofti lymphatic filariasis from 2001 to 2017 in Burkina Faso

    by Abdoulaye Sawadogo, Jacques Zoungrana, Arsène Gafourou Ouédraogo, Ismaël Diallo, Mahamadi Tassembedo, Appolinaire Kima, Mamadou Sermé, Boukary Ouédraogo, Aristophane Koffi Tanon, Serges Paul Eholié

    Background: Lymphatic filariasis is a neglected parasitic transmitted disease that the world has pledged to eliminate by 2020. Burkina Faso has initiated an elimination programme from 2001 to 2017. The aim of this study was to describe the impact of annual mass drug administration of ivermectin and albendazole on lymphatic filariasis transmission.Methods: This was an ecological study conducted covering the period from 2001 to 2017. The data were collected from 1 January to 31 December 2017. In this study, we have considered data pertaining to the annual distribution of treatment according to geographical location, sex, age, and the various post‐treatment evaluations, including the antigenic test and the microscopic search for microfilariae. All health districts implementing mass drug administration were included. The statistical analyses were descriptive using STATA software version 15.Results: During reviewing 16 years data of program implementation, the geographical coverage of health districts was complete 70/70 (100%). The average treatment coverage was 80%. Microfilaremia was less than 1% in 21 of the 30 sentinel sites. Post‐treatment surveillance showed that the prevalence of filarial antigen was less than 1% at 2, 4, and 6 years after. Of the 70 endemic health districts, 87% (61/70) interrupted transmission.Conclusion: Lymphatic filariasis transmission was interrupted in several health districts. Transmission assessment surveys showed a significant reduction of immunoparasitological indicators during program implementation. However, the country had to make efforts to reach the WHO target by 2020.


  • Cholécystite alithiasique au cours de la dengue : à propos de 3 cas

    by Salamata Sanfo, Arsene Gafourou Ouédraogo, Arouna Gnamou, Christiane C. Bere Some, Ismaël Diallo, Boureima Bagaya, Abdoulaye Sawadogo, Mikaila Kabore, Hamadé Zonon, Apoline K. Sondo, et al.

  • Open Access

    Manifestations adverses post immunisation chez les agents de santé vaccinés contre la COVID-19 au Centre Hospitalier Universitaire Yalgado Ouédraogo en 2022

    by A Sawadogo, Et Al

    Introduction : Les manifestations adverses post immunisations (MAPI) représentent l’ensemble desincidents survenant après une vaccination. Le développement rapide des vaccins contre la COVID-19a suscité des rumeurs et des inquiétudes. Alors, il s’avère nécessaire d'évaluer les MAPI notifiées parles agents de santé, afin de contribuer à lutter contre la réticence et l’hésitation à la vaccination. Matérielet méthodes : Une étude transversale auprès des agents de santé vaccinés a été réalisée dans le CentreHospitalier Universitaire Yalgado Ouédraogo du 14 Juin 2021 au 13 Mars 2022. Une régressionlogistique uni et multivariée au seuil de significativité statistique de 0,05 a été utilisée pour identifierles facteurs associés. Résultats : L’étude a concerné 247 agents de santé chez qui 212 (32,8%) ontprésenté au moins un MAPI dont 210 mineures et deux majeures. L’âge moyen était de 41,7± 0,8 ans.Le sexe ratio était de 2,4. Parmi eux, le personnel médical et paramédical était respectivement aunombre de 157(63,6%) et 90(36,4%). Les différentes MAPI survenant en moins de 24h étaient lescéphalées (51,8%), douleurs au point d’injection (47,8%), myalgies (44,1%), asthénie (42,5%) et lafièvre (35,2%). Dans 1/3 des cas, elles disparaissaient en moins de 24h. Les participants âgés de plusde 45 ans (OR= 2,17[1-4,7], p=0,049) et de sexe féminin (OR= 3,04[1,1-8,30], p=0,029) étaient associésà la survenue de MAPI. Conclusion : L’étude des MAPI liées aux vaccins anti-COVID-19 chez lesagents de santé permet de renforcer l’adhésion vaccinale pour une meilleure lutte contre cette pandémieà Coronavirus

  • Itinéraire de soins des cas de rage au Centre Hospitalier Universitaire Yalgado Ouédraogo au Burkina Faso

    by K. Apoline Sondo, G. Arsène Ouédraogo, Ismaèl Diallo, Ouedan Idogo, E. Arnaud Diendéré, Abdoulaye Sawadogo, Mikaila Kaboré, Arouna Gnamou, Jacques Zougrana, Oumaima Djarma, et al.


  • Open Access

    Impact of mass drug treatment with albendazole and ivermectin on transmission of Wuchereria Bancrofti lymphatic filariasis in Burkina Faso from 2001 to 2017

    by Abdoulaye Sawadogo, Apolline Ouédraogo/Sondo, Ismaêl Diallo, Affoué Gisèle Kouakou, Gafourou Arsène Ouédraogo, Mahamadi Tassembedo, Appolinaire Kima, Mamadou Sermé, Boukary Ouédraogo, Koffi Aristophane Tanon, et al.

    Background Lymphatic filariasis or bancroftosis is a neglected tropical parasitic disease that the world has resolved to eliminate by 2020. From 2001 to 2017, Burkina Faso has initiated a program to eliminate the disease. The objective of this study is then to describe the impact of annual mass drug administration (MDA) with ivermectin and albendazole on the transmission of lymphatic filariasis. Methods This was a descriptive ecological observational study that took place from January 1st to 31st December 2017 and covered the period from 2001 to 2017. All health districts implementing MDA with ivermectin and albendazole in Burkina Faso were included in the survey. Data related to treatment and transmission assessment surveys were collected and analyzed using STATA version 15. QGIS software version 2.18.25 was used to create the maps. Results During the 16 years of the program’s implementation, the geographic coverage of health districts was entirely completed (100%). The average treatment coverage rate was 80%. Microfilaremia was less than 1% in 21 of the 30 sentinel sites. Continuing endemic sites had a higher prevalence of filarial antigen and initial microfilaremia. Post-treatment surveillance showed a prevalence of filarial antigen of 0.28% at 2 years, 0.08% at 4 years and 0.02% at 6 years respectively. Out of a total of 70 health districts that were endemic, 87% (61/70) interrupted transmission of lymphatic filariasis. Conclusion Filariasis transmission was interrupted in several health districts. Evaluations showed a significant decrease of immuno-parasitological indicators during the implementation of the program, but the country did not achieve the goal.

  • Open Access

    Future of HIV2 and HIV2 + 1 Infected Patients Treated with Antiretrovirals Followed at the Day Hospital HIV Care Unit from 2011 to 2015

    by Ismaël Diallo, Smaïla Ouédraogo, Abdoulaye Sawadogo, Gafourou Arsène Ouédraogo, Eric Arnaud Diendéré, Jacques Zoungrana, Apoline Kongnimissom Sondo, Réné Bognounou, Mamoudou Savadogo, Armel Poda, et al.

    Introduction: HIV2 is endemic in West Africa. In Burkina Faso, its prevalence was estimated at 2%. The aim of this work was to evaluate the follow-up of patients and also to contribute to the availability of data. Methods: We involved 18 years or older. Infection was screened according to the national algorithm. A cross- sectional study from first June 2017 to 31 December 2017 was performed. For each patient, sociodemographic, clinical, biological, therapeutic and evolution data were collected and analyzed. Results: The proportion of patients infected with HIV2 (n = 48; 1.7%) and HIV2 + 1 (n = 67; 2.4%) was 4.3%. The sex rat mean age was 50.3 ± 8.5 years. The combination of 2INTI + LPV/r was the most prescribed (n = 73; 63.5%). The average gain of LTCD4 has evolved from + 236 cells/mm3 in 2011 to + 364 cells/mm3 in 2015. The retention rate at grade 5 was about 70%. Conclusion: The immunological and clinic response of the patients was satisfactory. More than half of the patients remained in the continuum of care after five years of follow-up.


  • Open Access

    Predictors of severe hypoxemia among COVID-19 patients in Burkina Faso (West Africa): Findings from hospital based cross-sectional study

    by Eric Arnaud Diendéré, Kongnimissom Apoline Sondo, Abdoul Risgou Ouédraogo, Désiré Lucien Dahourou, Kadari Cissé, Abdoulaye Sawadogo, Soumaila Maiga, Marcel Kuiré, Seidou Zida, Pierre R. Kaboré, et al.